Callan Capital, LLC

13F Portfolio Filings

Most recent 13F
Q3 2024
Location
La Jolla, CA
CIK
0001542166
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2024 349 1,431,695 SCHB, META, FNDX, SCHF 13F-HR 11/12/2024 000154216624000015
Q2 2024 314 1,215,269 SCHB, FNDX, SCHF, FNDF NEW HOLDINGS 10/22/2024 000154216624000013
Q2 2024 310 1,199,140 SCHB, FNDX, SCHF, FNDF 13F-HR 8/12/2024 000154216624000009
Q1 2024 297 1,137,703 SCHB, FNDX, SCHF, FNDF NEW HOLDINGS 10/22/2024 000154216624000011
Q1 2024 297 1,135,004 SCHB, FNDX, SCHF, FNDF 13F-HR 5/3/2024 000154216624000005
Q4 2023 234 1,059,753 SCHB, SCHF, FNDX, FNDF 13F-HR 2/2/2024 000154216624000003
Q3 2023 204 933,916 SCHB, SCHF, FNDX, FNDF 13F-HR 11/6/2023 000154216623000013
Q2 2023 183 904,077 SCHB, SCHF, FNDF, FNDX 13F-HR 8/4/2023 000154216623000011
Q1 2023 184 863,797 SCHB, SCHF, FNDF, GSIE RESTATEMENT 6/13/2023 000154216623000009
Q4 2022 186 809,650 SCHB, SCHF, FNDF, GSIE RESTATEMENT 6/13/2023 000154216623000007
Q3 2022 129 614,229 SCHB, SCHF, FNDF, PRF 13F-HR 11/14/2022 000154216622000011
Q2 2022 112 648,379 SCHB, SCHF, FNDF, PRF 13F-HR 8/15/2022 000154216622000009
Q1 2022 122 727,847 SCHB, SCHF, FNDX, FNDF 13F-HR 5/10/2022 000154216622000004
Q4 2021 133 688,032 SCHB, SCHF, GSLC, PRF 13F-HR 1/21/2022 000154216622000002
Q3 2021 87 601,512 SCHB, SCHF, GSLC, PRF 13F-HR 10/14/2021 000154216621000009
Q2 2021 89 575,330 SCHB, SCHF, GSLC, PRF 13F-HR 8/10/2021 000154216621000007
Q1 2021 86 549,847 SCHB, SCHF, GSLC, PRF 13F-HR 5/10/2021 000154216621000005
Q4 2020 83 491,590 SCHB, SCHF, GSLC, PRF 13F-HR 2/2/2021 000154216621000003
Q3 2020 78 445,541 SCHB, GSLC, SCHF, PRF 13F-HR 10/23/2020 000154216620000008
Q2 2020 86 398,819 SCHB, SCHF, PRF, GSLC 13F-HR 8/4/2020 000154216620000006
Q1 2020 81 324,804 PRF, VEU, GSIE, SCHF 13F-HR 5/8/2020 000154216620000004
Q4 2019 56 363,845 PRF, VEU, IWB, GSIE 13F-HR 2/14/2020 000154216620000002
Q3 2019 53 349,113 PRF, VEU, IWB, GSIE 13F-HR 11/14/2019 000154216619000008
Q2 2019 54 310,562 PRF, VEU, MLPX, VXUS 13F-HR 8/12/2019 000154216619000006
Q1 2019 53 306,329 PRF, VEU, MLPX, VXUS 13F-HR 5/14/2019 000154216619000004
Q4 2018 52 274,468 PRF, VEU, VXUS, MLPX 13F-HR 2/14/2019 000154216619000002
Q3 2018 50 302,926 PRF, VEU, MLPX, GSLC 13F-HR 11/13/2018 000154216618000008
Q2 2018 49 288,564 PRF, VEU, MLPX, GSLC 13F-HR 8/10/2018 000154216618000006
Q1 2018 51 308,813 PRF, VEU, SHM, GSLC 13F-HR 5/4/2018 000154216618000004
Q4 2017 51 287,206 PRF, VEU, GSLC, XLK 13F-HR 2/13/2018 000154216618000002
Q3 2017 50 268,100 VEU, PRF, GSLC, XLK 13F-HR 11/8/2017 000154216617000008
Q2 2017 51 264,418 VEU, PRF, GSLC, XLK 13F-HR 8/8/2017 000154216617000006
Q1 2017 49 250,543 PRF, VEU, GSLC, XLK 13F-HR 5/10/2017 000154216617000004
Q4 2016 37 222,200 PRF, VEU, GSLC, XLK 13F-HR 2/9/2017 000154216617000002
Q3 2016 44 242,840 PRF, VEU, IBRX, GSLC 13F-HR 11/15/2016 000154216616000019
Q2 2016 68 244,945 PRF, VEU, IBRX, GSLC 13F-HR 8/12/2016 000154216616000017
Q1 2016 63 238,523 PRF, VEU, IBRX, GSLC 13F-HR 5/11/2016 000154216616000015
Q4 2015 64 252,784 IBRX, PRF, VEU, XLK 13F-HR 2/12/2016 000154216616000011
Q3 2015 62 184,261 IBRX, PRF, XLK, VCSH 13F-HR 11/10/2015 000154216615000009
Q2 2015 70 476,503 RCPT, PRF, SDY, VGK 13F-HR 8/13/2015 000154216615000007
Q1 2015 68 470,081 RCPT, SDY, PRF, VGK 13F-HR 5/11/2015 000154216615000005
Q4 2014 72 440,754 RCPT, SDY, PRF, Sorrento Therapeutics 13F-HR 2/10/2015 000154216615000003
Q3 2014 65 361,444 RCPT, SDY, PRF, VGK 13F-HR 11/12/2014 000154216614000012
Q2 2014 74 373,917 SDY, RCPT, PRF, VGK 13F-HR 8/13/2014 000154216614000009
Q1 2014 55 299,592 SDY, PRF, VGK, RCPT 13F-HR 5/8/2014 000154216614000005
Q4 2013 54 261,643 SDY, PRF, VGK, AMLP RESTATEMENT 2/13/2014 000154216614000003
Additional filings from Callan Capital, LLC that have since been restated